Citizen Genetics provides ongoing monitoring of genetic test results against evolving scientific literature and clinical trial data. The service addresses the challenge of static genetic reports by continuously tracking reclassifications of variants of uncertain significance (VUS). This patient-led precision medicine approach ensures individuals receive timely updates on new findings relevant to their existing genetic diagnoses.
Funding
Funding not disclosed
Founders
Product
Problem
Patients who undergo genetic testing may receive inconclusive results, termed variants of uncertain significance (VUS), which can be reclassified over time as new scientific evidence emerges. Patients are not always informed when VUS are reclassified, potentially impacting their healthcare decisions. Keeping up with evolving genetic science, clinical trials, and therapies can be overwhelming for patients and healthcare providers.
Solution
Citizen Genetics provides a personalized toolkit and ongoing updates to help patients and providers track the evolving science related to their genetic variants. The company monitors variant events, clinical trial launches, therapy launches, and guideline changes, delivering allele alerts when new information becomes available. Citizen Genetics also offers personalized reports summarizing the clinical context of a patient's variant, gene, and condition, as well as regular community updates on the latest in genetics. This service enables patients to stay informed about their genetic predispositions and access personalized medicine options.
Target Audience
Citizen Genetics targets individual patients who have undergone genetic testing, particularly those with VUS results, as well as genetic counselors and healthcare providers seeking to stay informed about the latest developments in genomic science.
Features
- Personalized variant briefs summarizing the clinical context of a patient's variant, gene, and condition
- Allele Alerts notifying users of variant reclassifications, clinical trial launches, therapy launches, and guideline changes
- Curated literature feed, informing users of relevant scientific publications
- Community updates providing the latest information in genetics
- Pre-drafted patient outreach communications for providers